Cold-cough

Commercial

Portfolio-7447-for-WEB

NCE Pipeline

Discovery-7447-for-WEB

Research

Latest Report and Accounts 

Vernalis plc - AR 30-06-2017 - COVER PAGE FOR WEBSITE Page 001

30 June, 2017 Results

Download our latest report...

Archive

Latest Presentation

ceo12 September, 2017

Our latest presentation is available to view from here...

Archive

Share Price

Share price:  12.88p
Change:  0.38 (2.97%)
As at:  20 October 2017 15:23:52
Volume:  62,640
LSE ID:  VER

Share price details

Latest News

Results Announcement for the year ended 30 June 2017

Vernalis plc (LSE: VER) today announces its audited financial results for the year ended 30 June 2017, following the year-end trading update published on 18 July 2017.

 

Read more ...

At a glance

More information on Vernalis and its pipeline ...

FactsheetNov14 Company fact sheet

Comm thumbnail Explore the pipeline ...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch